Intratumoral delivery of tavokinogene telseplasmid yields systemic immune responses in metastatic melanoma patients.
Annals of oncology : official journal of the European Society for Medical Oncology
Intratumoral Plasmid IL12 Electroporation Therapy in Patients with Advanced Melanoma Induces Systemic and Intratumoral T-cell Responses.
Cancer immunology research
Intratumoral and Combination Therapy in Melanoma and Other Skin Cancers.
American journal of clinical dermatology
Phase II Study of Perioperative Immunotherapy in Patients With Advanced Non-Virally Associated ...
Intratumoral CD3+ T-cells will be identified by immunohistochemistry in pre- and post-treatment tumor specimens. The proportion of patients with a >= 40% increase (from pre- to post-treatment) will be calculated. The exact 95% con...
A Randomized Phase 2 Study of Cemiplimab ± ISA101b in HPV16-Positive OPC
Measured using RECIST 1.1
Efficacy Study of Pembrolizumab in Relapsed, Locally Recurrent Squamous Cell Cancer of the Head...